Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

Study ID: NCT07147205
Start Date: 2026-02-05
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Study ID: NCT06412120
Start Date: 2025-12-01
End Date: 2030-10-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

70

Intervention / Treatment

absolute

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

Study ID: NCT06824818
Start Date: 2026-06
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

155

Intervention / Treatment

LHRH Agonist Therapy Discontinuation

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Study ID: NCT07174310
Start Date: 2025-12-31
End Date: 2031-07-25
Study Type

Interventional

Study Phase

Phase3

No. of Participants

900

Intervention / Treatment

Prasinezumab

Placebo

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Study ID: NCT07198074
Start Date: 2025-12-15
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

255

Intervention / Treatment

bevacizumab

Biospecimen Collection

Carboplatin

Computed Tomography

Magnetic Resonance Imaging

Paclitaxel

Pembrolizumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

Study ID: NCT07068074
Start Date: 2025-12-12
End Date: 2031-01-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

428

Intervention / Treatment

Wide local Excision

Sentinel Lymph Node and Wide Local Excision

Sponsor

Eastern Cooperative Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Driving After Shoulder Surgery

Study ID: NCT04196218
Start Date: 2025-12
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Driving simulator

Sponsor

The Hawkins Foundation

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Study ID: NCT07211438
Start Date: 2026-04-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Psilocybin

Sponsor

Centre for Addiction and Mental Health

Source: clinicaltrials.gov

Share:
Add to list

Study of NM8074 in Patients with Dermatomyositis (DM)

Study ID: NCT06887738
Start Date: 2026-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

8

Intervention / Treatment

NM8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Study ID: NCT04630847
Start Date: 2025-12
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

Fecal Microbiota Transplant

Sponsor

ProgenaBiome

Source: clinicaltrials.gov

Share:
Add to list